PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
2579318-0	1985	Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.	Bleomycin	9-18	calmodulin 2	Mus musculus	60-70	
2579318-1	1985	A wide variety of structurally different calmodulin antagonists enhanced the cytotoxicity of bleomycin A2 to leukemic L1210 cells.	Bleomycin	93-105	calmodulin 2	Mus musculus	41-51	
2579318-3	1985	The most potent blockers of L1210 calmodulin activity, melittin and mastoparan, were the most potent potentiators of bleomycin A2 cytotoxicity.	Bleomycin	117-129	calmodulin 2	Mus musculus	34-44	
2451030-1	1988	Phenothiazines and structurally related calmodulin antagonists acted synergistically with bleomycin in killing malignant cells in culture.	Bleomycin	90-99	calmodulin 2	Mus musculus	40-50	
2441572-0	1987	Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine.	Bleomycin	31-40	calmodulin 2	Mus musculus	94-104	
2441572-1	1987	It has been shown that inhibitors of calmodulin can increase the sensitivity of rodent cells to Bleomycin by interfering with DNA repair functions.	Bleomycin	96-105	calmodulin 2	Mus musculus	37-47	
2428790-0	1986	Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumor cells.	Bleomycin	15-24	calmodulin 2	Mus musculus	45-55	
2418860-2	1986	Evidence in the literature suggests that hyperthermia (HT) or inhibitors of calmodulin can increase the sensitivity of rodent cells to bleomycin (BLM) by interfering with DNA repair functions.	Bleomycin	135-144	calmodulin 2	Mus musculus	76-86